Literature DB >> 21506733

Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles.

Henry C Y Chung1, Ruby C Y Lin, Grant J Logan, Ian E Alexander, Perminder S Sachdev, Kuldip S Sidhu.   

Abstract

Use of animal feeder layers and serum containing media in the derivation and propagation of induced pluripotent stem cells (iPSCs) can hinder clinical translation, because of the presence of xeno-material/pathogens. A defined and standardized system would be ideal for generating a homogenous population of iPSCs, which closely resembles human embryonic stem cells (hESCs). This article presents a novel and extensive comparison between in-house produced iPSCs and hESCs under "feeder" and "feeder-free" conditions, using transcriptomic genome-wide microarray analysis. We generated a list of pluripotency-associated and bivalent domain-containing genes by meta-analysis to measure qualitatively the degree of reprogramming in feeder-free derived iPSCs, in which both profiles displayed similar levels of gene expression as in hESCs. Gene ontology analysis showed that feeder-free iPSCs have enriched terms belonging to DNA repair/replication and cell cycle, which are signature to pluripotent cells. Transcriptomic data combined with directed differentiation assays, indicated that variability among iPSC lines is minimized when using a feeder-free cultural system, which may serve as a platform for further developing regenerative medicine compliant human iPSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506733      PMCID: PMC3258437          DOI: 10.1089/scd.2010.0440

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  40 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

3.  Dissecting direct reprogramming through integrative genomic analysis.

Authors:  Tarjei S Mikkelsen; Jacob Hanna; Xiaolan Zhang; Manching Ku; Marius Wernig; Patrick Schorderet; Bradley E Bernstein; Rudolf Jaenisch; Eric S Lander; Alexander Meissner
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

4.  Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells.

Authors:  Xiao Dong Zhao; Xu Han; Joon Lin Chew; Jun Liu; Kuo Ping Chiu; Andre Choo; Yuriy L Orlov; Wing-Kin Sung; Atif Shahab; Vladimir A Kuznetsov; Guillaume Bourque; Steve Oh; Yijun Ruan; Huck-Hui Ng; Chia-Lin Wei
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

5.  Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells.

Authors:  Guangjin Pan; Shulan Tian; Jeff Nie; Chuhu Yang; Victor Ruotti; Hairong Wei; Gudrun A Jonsdottir; Ron Stewart; James A Thomson
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

6.  A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.

Authors:  Dirk Hockemeyer; Frank Soldner; Elizabeth G Cook; Qing Gao; Maisam Mitalipova; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

7.  Derivation of a new human embryonic stem cell line, endeavour-1, and its clonal propagation.

Authors:  Kuldip S Sidhu; John P Ryan; Bernie E Tuch
Journal:  Stem Cells Dev       Date:  2008-02       Impact factor: 3.272

8.  Wnt signaling promotes reprogramming of somatic cells to pluripotency.

Authors:  Alexander Marson; Ruth Foreman; Brett Chevalier; Steve Bilodeau; Michael Kahn; Richard A Young; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-08-07       Impact factor: 24.633

9.  Regulatory networks define phenotypic classes of human stem cell lines.

Authors:  Franz-Josef Müller; Louise C Laurent; Dennis Kostka; Igor Ulitsky; Roy Williams; Christina Lu; In-Hyun Park; Mahendra S Rao; Ron Shamir; Philip H Schwartz; Nils O Schmidt; Jeanne F Loring
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  13 in total

Review 1.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

2.  Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.

Authors:  Budd A Tucker; Kristin R Anfinson; Robert F Mullins; Edwin M Stone; Michael J Young
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

3.  Effects of sesamin on the biosynthesis of chondroitin sulfate proteoglycans in human articular chondrocytes in primary culture.

Authors:  Peraphan Pothacharoen; Sumet Najarus; Jongkolnee Settakorn; Shuji Mizumoto; Kazuyuki Sugahara; Prachya Kongtawelert
Journal:  Glycoconj J       Date:  2013-12-12       Impact factor: 2.916

4.  Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells.

Authors:  María Salazar-Roa; Marianna Trakala; Mónica Álvarez-Fernández; Fátima Valdés-Mora; Cuiqing Zhong; Jaime Muñoz; Yang Yu; Timothy J Peters; Osvaldo Graña-Castro; Rosa Serrano; Elisabet Zapatero-Solana; María Abad; María José Bueno; Marta Gómez de Cedrón; José Fernández-Piqueras; Manuel Serrano; María A Blasco; Da-Zhi Wang; Susan J Clark; Juan Carlos Izpisua-Belmonte; Sagrario Ortega; Marcos Malumbres
Journal:  EMBO J       Date:  2020-07-02       Impact factor: 11.598

5.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

Review 6.  Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.

Authors:  Lezanne Ooi; Kuldip Sidhu; Anne Poljak; Greg Sutherland; Michael D O'Connor; Perminder Sachdev; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

7.  "Footprint-free" human induced pluripotent stem cell-derived astrocytes for in vivo cell-based therapy.

Authors:  Elisabetta Mormone; Sunita D'Sousa; Vera Alexeeva; Maria M Bederson; Isabelle M Germano
Journal:  Stem Cells Dev       Date:  2014-07-25       Impact factor: 3.272

8.  Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells.

Authors:  Akshayalakshmi Sridhar; Melissa M Steward; Jason S Meyer
Journal:  Stem Cells Transl Med       Date:  2013-03-19       Impact factor: 6.940

9.  Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions.

Authors:  Chad C Macarthur; Andrew Fontes; Namritha Ravinder; David Kuninger; Jasmeet Kaur; Matthew Bailey; Antje Taliana; Mohan C Vemuri; Pauline T Lieu
Journal:  Stem Cells Int       Date:  2012-03-22       Impact factor: 5.443

10.  To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture.

Authors:  Charlotte A Willmann; Hatim Hemeda; Lisa A Pieper; Michael Lenz; Jie Qin; Sylvia Joussen; Stephanie Sontag; Paul Wanek; Bernd Denecke; Herdit M Schüler; Martin Zenke; Wolfgang Wagner
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.